Facebook
Twitter
Telegram
Report an ErrorVaxcyte Financial Statements 2011-2024 | PCVX
Annual Financial Statements Vaxcyte
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
7.86 B | 2.74 B | 1.2 B | 696 M | - | - | - | - | - | - | - | - | - |
Shares |
97.2 M | 64.9 M | 51.9 M | 29.5 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
80.9 | 42.2 | 23.2 | 23.6 | - | - | - | - | - | - | - | - | - |
Net Income |
-402 M | -223 M | -100 M | -89.2 M | -50.3 M | -29.5 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-468 M | -232 M | -104 M | -89.6 M | -54.2 M | -35.5 M | - | - | - | - | - | - | - |
Interest Expense |
- | 2 K | 7 K | 7 K | 40 K | 75 K | - | - | - | - | - | - | - |
EBITDA |
-465 M | -230 M | -102 M | -88.2 M | -52.7 M | -34.5 M | - | - | - | - | - | - | - |
Operating Expenses |
468 M | 232 M | 104 M | 89.6 M | 53.9 M | 35.5 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
60.7 M | 39.8 M | 25.3 M | 16 M | 8.55 M | 5.39 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Vaxcyte
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
112 M | 95.4 M | 102 M | 98.1 M | 86.2 M | 79.5 M | 62 M | 60.8 M | 57.5 M | 53 M | 52.2 M | 51.5 M | 51.2 M | 51 M | 50.9 M | 11.8 M | 4.05 M | 3.97 M | 3.86 M | 3.68 M | 3.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-95 M | - | -92.7 M | -68.3 M | -60.5 M | - | -57.9 M | -48.5 M | -39 M | - | -26.6 M | -23.7 M | -21.2 M | -20.7 M | -21 M | -20.3 M | -27.1 M | -14.6 M | -11.3 M | -10.7 M | -13.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-114 M | - | -113 M | -87.1 M | -71.2 M | - | -58.6 M | -47.9 M | -39.2 M | - | -27 M | -23.7 M | -23.1 M | -19.5 M | -21.3 M | -21.2 M | -27.6 M | -15.8 M | -12.1 M | -12.2 M | -13.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
19.5 M | - | - | - | 10.7 M | - | - | 2 K | 235 K | - | 336 K | 7 K | 1.92 M | -1.28 M | 7 K | 7 K | 7 K | 1.22 M | 9 K | 11 K | 273 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-113 M | - | -112 M | -86.3 M | -70.5 M | - | -57.9 M | -47.3 M | -38.6 M | - | -25.6 M | -22.9 M | -22.8 M | -19.5 M | -20.2 M | -20.5 M | -27.2 M | -15.8 M | -11.2 M | -11.6 M | -13.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
114 M | - | 113 M | 87.1 M | 71.2 M | - | 58.6 M | 47.9 M | 39.2 M | - | 27 M | 23.7 M | 23.1 M | 19.5 M | 21.3 M | 21.2 M | 27.6 M | 15.8 M | 12.1 M | 12.2 M | 13.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
19.9 M | - | 15.6 M | 14.5 M | 13.1 M | - | 10.9 M | 9.42 M | 7.54 M | - | 6.52 M | 6.08 M | 5.88 M | 4.79 M | 4.9 M | 3.05 M | 3.28 M | 2.46 M | 2.51 M | 2.26 M | 1.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency